Journal article
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
- Abstract:
- Prefrontal cortex has been shown to regulate striatal dopaminergic function via glutamatergic mechanisms in preclinical studies. Concurrent disruption of these systems is also often seen in neuropsychiatric disease. The simultaneous measurement of striatal dopamine signaling, cortical gray matter, and glutamate levels is therefore of major interest, but has not been previously reported. In the current study, twenty-eight healthy subjects underwent 2 simultaneous [11C]-( + )-PHNO PET-MRI scans, once after placebo and once after amphetamine in a double-blind randomized cross-over design, to measure striatal dopamine release, striatal dopamine receptor (D2/3R) availability, anterior cingulate glutamate+glutamine (Glx) levels, and cortical gray matter volumes at the same time. Voxel-based morphometry was used to investigate associations between neurochemical measures and gray matter volumes. Whole striatum D2/3R availability was positively associated with prefrontal cortex gray matter volume (pFWE corrected = 0.048). This relationship was mainly driven by associative receptor availability (pFWE corrected = 0.023). In addition, an interaction effect was observed between sensorimotor striatum D2/3R availability and anterior cingulate Glx, such that in individuals with greater anterior cingulate Glx concentrations, D2/3R availability was negatively associated with right frontal cortex gray matter volumes, while a positive D2/3R-gray matter association was observed in individuals with lower anterior cingulate Glx levels (pFWE corrected = 0.047). These results are consistent with the hypothesis that the prefrontal cortex is involved in regulation of striatal dopamine function. Furthermore, the observed associations raise the possibility that this regulation may be modulated by anterior cingulate glutamate concentrations
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.6MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41380-022-01596-6
- Publication website:
- https://discovery.ucl.ac.uk/10148720/1/Nour_s41380-022-01596-6.pdf
Authors
+ RCUK | Medical Research Council
More from this funder
- Funder identifier:
- 10.13039/501100000265
- Grant:
- MC_U120097115
+ DH | National Institute for Health Research
More from this funder
- Funder identifier:
- 10.13039/501100000272
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- Molecular Psychiatry More from this journal
- Volume:
- 27
- Issue:
- 8
- Pages:
- 3493-3500
- Publication date:
- 2022-05-11
- DOI:
- EISSN:
-
1476-5578
- ISSN:
-
1359-4184
- Language:
-
English
- Keywords:
- Pubs id:
-
1274449
- Local pid:
-
pubs:1274449
- Source identifiers:
-
W4280517603
- Deposit date:
-
2026-04-28
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record